For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Biogen Inc’s stock clocked out at $189.07, down -2.60% from its previous closing price of $194.12. In other words, the price has decreased by -$2.60 from its previous closing price. On the day, 1.54 million shares were traded. BIIB stock price reached its highest trading level at $194.56 during the session, while it also had its lowest trading level at $188.78.
Ratios:
To gain a deeper understanding of BIIB’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.43 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.60. For the most recent quarter (mrq), Quick Ratio is recorded 1.48 and its Current Ratio is at 2.29. In the meantime, Its Debt-to-Equity ratio is 0.43 whereas as Long-Term Debt/Eq ratio is at 0.42.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on February 14, 2024, Reiterated its Buy rating but revised its target price to $300 from $305 previously.
On February 14, 2024, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $315 to $240.
UBS Downgraded its Buy to Neutral on January 24, 2024, whereas the target price for the stock was revised from $311 to $276.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Sep 03 ’24 when Singhal Priya sold 431 shares for $204.22 per share. The transaction valued at 88,019 led to the insider holds 5,316 shares of the business.
Singhal Priya bought 431 shares of BIIB for $88,019 on Sep 03 ’24. On Apr 02 ’24, another insider, Singhal Priya, who serves as the Head of Development of the company, sold 93 shares for $213.09 each. As a result, the insider received 19,817 and left with 4,886 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BIIB now has a Market Capitalization of 27540316160 and an Enterprise Value of 32290846720. As of this moment, Biogen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.81, and their Forward P/E ratio for the next fiscal year is 10.99. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 6.61. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.97 while its Price-to-Book (P/B) ratio in mrq is 1.73. Its current Enterprise Value per Revenue stands at 3.339 whereas that against EBITDA is 11.832.
Stock Price History:
Over the past 52 weeks, BIIB has reached a high of $269.43, while it has fallen to a 52-week low of $189.44. The 50-Day Moving Average of the stock is -8.48%, while the 200-Day Moving Average is calculated to be -15.28%.
Shares Statistics:
It appears that BIIB traded 1.01M shares on average per day over the past three months and 1358540 shares per day over the past ten days. A total of 144.90M shares are outstanding, with a floating share count of 144.53M. Insiders hold about 0.77% of the company’s shares, while institutions hold 89.09% stake in the company. Shares short for BIIB as of 1724976000 were 3337604 with a Short Ratio of 3.64, compared to 1722384000 on 2734637. Therefore, it implies a Short% of Shares Outstanding of 3337604 and a Short% of Float of 2.5899999.
